Rheumatology Advance Access originally published online on April 25, 2007
Rheumatology 2007 46(7):1207-1208; doi:10.1093/rheumatology/kem080
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
LETTERS TO THE EDITOR |
Successful patient recruitment in investigator-led clinical trials
Rheumatology Department, Selly Oak Hospital, Birmingham and 1Epidemiology Group, Department of Public Health, University of Aberdeen, UK.
Correspondence to: S. J. Bowman, PhD, FRCP, Rheumatology Department, Selly Oak Hospital, Raddlebarn Road, Selly Oak, Birmingham B29 6JD, UK. E-mail: simon.bowman@uhb.nhs.uk
| The first 10% of the full text of this article appears below. |
SIR, The Academic Rheumatology Community in the UK has an excellent track record in organizing investigator-led clinical therapeutic trials. Since 1999 a formal scheme for funding such trials has been in operation through a collaboration between the Arthritis Research Campaign (ARC), the British Society for Rheumatology (BSR), the Medical Research Council (MRC) and the British Orthopaedic Association (BOA).
There is a substantial literature in the public domain to guide those applying for funding for clinical trial support